Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: Protective role of brain CRF

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 4 39-4, 1999, Pages

  Million, Mulugeta ^a,b   Taché, Yvette ^a   Anton, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2,4,6 trinitrobenzenesulfonic acid; Astressin; Brain; Colon; Corticotropin releasing factor; Food intake; Myeloperoxidase

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CORTICOSTEROID BLOOD LEVEL; CORTICOSTERONE RELEASE; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; FEMALE; FOOD INTAKE; HORMONAL REGULATION; HORMONE RESPONSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; TISSUE INJURY; WEIGHT GAIN;

EID: 0032911862     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.4.g1027     Document Type: Article

References (51)

1. Abe, R., T. Shimosegawa, Y. Kikuchi, K. Kimura, Y. Nagasaki, M. Koizumi, and T. Toyota. The role of pituitary-adrenal counterregulation of inflammation in cerulein-induced pancreatitis: a comparison between Fischer and Lewis rats. Pancreas 12: 280-285, 1996.
2. Anton, P. A., and F. Shanahan. Neuroimmunomodulation in inflammatory bowel disease: how far from "bench" to "bedside"? Ann. NY Acad. Sci. 840: 723-735, 1998.
3. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290, 1995.
4. Bennett, E. J., C. C. Tennant, C. Piesse, J. Badcock, and J. Kellow. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 43: 256-261, 1998.
5. Berin, M. C., and M. H. Perdue. Effect of psychoneural factors on intestinal epithelial function. Can. J. Gastroenterol. 11: 353-357, 1997.
6. Besedovsky, H. O., and R. A. Del. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17: 64-102, 1996.
7. Bonaz, B., and Y. Taché. Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor. Brain Res. 641: 21-28, 1994.
8. Calogero, A. E., E. M. Sternberg, G. Bagdy, C. Smith, R. Bernardini, S. Aksentijevich, R. L. Wilder, P. W. Gold, and G. P. Chrousos. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 55: 600-608, 1992.
9. Chang, F. C., and M. R. Opp. Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. Am. J. Physiol. 275 (Regulatory Integrative Comp. Physiol. 44): R793-R802, 1998.
10. Collins, S. M., K. McHugh, K. Jacobson, I. Khan, R. Riddell, K. Murase, and H. P. Weingarten. Previous inflammation alters the response of the rat colon to stress. Gastroenterology 111: 1509-1515, 1996.
11. De, S. E. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20: 789-819, 1995.
12. Dhabhar, F. S., B. S. McEwen, and R. L. Spencer. Adaptation to prolonged or repeated stress-comparison between rat strains showing intrinsic differences in reactivity to acute stress. Neuroendocrinology 65: 360-368, 1997.
13. 9-41 in three bioassay systems. Endocrinology 129: 1312-1316, 1991.
14. Gomez, F., A. Lahmame, K. E. De, and A. Armario. Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 63: 327-337, 1996.
15. Grisham, M. B., J. N. Benoit, and D. N. Granger. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol. 186: 729-742, 1990.
16. Gué, M., C. Bonbonne, J. Fioramonti, J. More, C. Del Rio-Lacheze, C. Comera, and L. Buéno. Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G84-G91, 1997.
17. Gulyas, J., C. Rivier, M. Perrin, S. C. Koerber, S. Sutton, A. Corrigan, S. L. Lahrichi, A. G. Graig, W. Vale, and J. Rivier. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl. Acad. Sci. USA 92: 10575-10579, 1995.
18. Haas, D. A., and S. R. George. Single or repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor. Brain Res. 461: 230-237, 1988.
19. Herman, J. P., and W. E. Cullinan. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20: 78-84, 1997.
20. Hogaboam, C. M., K. Jacobson, S. M. Collins, and M. G. Blennerhassett. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am. J. Physiol. 268 (Gastrointest. Liver Physiol. 31): G673-G684, 1995.
21. Kapcala, L. P., T. Chautard, and R. L. Eskay. The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress. Ann. NY Acad. Sci. 771: 419-437, 1995.
22. Karalis, K., L. J. Muglia, D. Bae, H. Hilderbrand, and J. A. Majzoub. CRH and the immune system. J. Neuroimmunol. 72: 131-136, 1997.
23. Kishimoto, T., R. V. Pearse, C. R. Lin, and M. G. Rosenfeld. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92: 1108-1112, 1995.
24. Lachuer, J., I. Delton, M. Buda, and M. Tappaz. The habituation of brainstem catecholaminergic groups to chronic daily restraint stress is stress specific like that of the hypothalamo-pituitary-adrenal axis. Brain Res. 638: 196-202, 1994.
25. Lenz, H. J., M. Burlage, A. Raedler, and H. Greten. Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat. Gastroenterology 94: 598-602, 1988.
26. Levenstein, S., C. Prantera, V. Varvo, M. L. Scribano, E. Berto, A. Andreoli, and C. Luzi. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am. J. Gastroenterol. 89: 1219-1225, 1994.
27. Linthorst, A. C., C. Flachskamm, S. J. Hopkins, M. E. Hoadley, M. S. Labeur, F. Holsboer, and J. M. Reul. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J. Neurosci. 17: 4448-4460, 1997.
28. Martinez, V., J. Rivier, L. Wang, and Y. Taché. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J. Pharmacol. Exp. Ther. 280: 754-760, 1997.
29. McCafferty, D. M., K. A. Sharkey, and J. L. Wallace. Beneficial effects of local or systemic lidocaine in experimental colitis. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G560-G567, 1994.
30. McCafferty, D. M., J. L. Wallace, and K. A. Sharkey. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G272-G280, 1997.
31. McCall, R. D., S. Haskill, E. M. Zimmermann, P. K. Lund, R. C. Thompson, and R. B. Sartor. Tissue interleukin-1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 106: 960-972, 1994.
32. Mekaouche, M., L. Givalois, G. Barbanel, P. Siaud, D. Maurel, F. Malaval, A. F. Bristow, J. Boissin, I. Assenmacher, and G. Ixart. Chronic restraint enhances interleukin-1-beta release in the basal state and after an endotoxin challenge, independently of adrenocorticotropin and corticosterone release. Neuroimmunomodulation 1: 292-299, 1994.
33. Misiewicz, B., E. Zelazowska, R. B. Raybourne, G. Cizza, and E. M. Sternberg. Inflammatory responses to carrageenan injection in LEW/N and F344/N rats: LEW/N rats show sex- and age-dependent changes in inflammatory reactions. Neuroimmunomodulation 3: 93-101, 1996.
34. Morris, G. P., P. L. Beck, M. S. Herridge, W. T. Depew, M. R. Szewczuk, and J. L. Wallace. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803, 1989.
35. Ottaway, C. A. Role of the neuroendocrine system in cytokine pathways in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10, Suppl. 2: 10-15, 1996.
36. Patchev, V. K., K. T. Kalogeras, P. Zelazowski, R. L. Wilder, and G. P. Chrousos. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats. Endocrinology 131: 1453-1457, 1992.
37. Perrin, M. H., S. W. Sutton, L. Cervini, J. E. Rivier, and W. W. Vale. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of CRF receptors. J. Pharmacol. Exp. Ther. 288: 729-734, 1999.
38. Rivier, C., J. Rivier, and S. Lee. Importance of pituitary and brain receptors for corticotropin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Brain Res. 721: 83-90, 1996.
39. Sartor, R. B., H. C. Rath, S. N. Lichtman, and T. E. Van. Animal models of intestinal and joint inflammation. Baillieres Clin. Rheumatol. 10: 55-76, 1996.
40. Schleimer, R. P. An overview of glucocorticoid anti-inflammatory actions. Eur. J. Clin. Pharmacol. 45, Suppl. 1: S3-S7, 1993.
41. Scott, L. V., and T. G. Dinan. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci. 62: 1985-1998, 1998.
42. Shibasaki, T., N. Yamauchi, M. Hotta, A. Masuda, H. Oono, I. Wakabayashi, N. Ling, and H. Demura. Brain corticotropin-releasing factor acts as inhibitor of stress-induced gastric erosion in rats. Life Sci. 47: 925-932, 1990.
43. Sternberg, E. M., J. R. Glowa, M. A. Smith, A. E. Calogero, S. J. Listwak, S. Aksentijevich, G. P. Chrousos, R. L. Wilder, and P. W. Gold. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res. 570: 54-60, 1992.
44. Stonerook, M. J., H. S. Weiss, M. A. Rodriguez, J. V. Rodriguez, J. I. Hernandez, O. C. Peck, and J. D. Wood. Temperature-metabolism relations in the cotton-top tamarin (Saguinus oedipus) model for ulcerative colitis. J. Med. Primatol. 23: 16-22, 1994.
45. Taché, Y., H. Mönnikes, B. Bonaz, and J. Rivier. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann. NY Acad. Sci. 697: 233-243, 1993.
46. Tocchi, A., L. Lepre, G. Liotta, G. Mazzoni, G. Costa, L. Taborra, and M. Miccini. Familial and psychological risk factors of ulcerative colitis. Ital. J. Gastroenterol. Hepatol. 29: 395-398, 1997.
47. Turnbull, A. V., and C. Rivier. Corticotropin-releasing factor (CRF) and endocrine response to stress: CRF receptors, binding protein, and related peptides. Proc. Soc. Exp. Biol. Med. 215: 1-10, 1997.
48. Vergnolle, N., C. Comera, J. More, M. Alvinerie, and L. Bueno. Expression and secretion of lipocortin 1 in gut inflammation are not regulated by pituitary-adrenal axis. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R623-R629, 1997.
49. Wallace, J. L., and B. C. Chin. Inflammatory mediators in gastrointestinal defense and injury. Proc. Soc. Exp. Biol. Med. 214: 192-203, 1997.
50. Wang, L., S. Cardin, V. Martinez, and Y. Taché. Intracerebroventricular CRF inhibits cold restraint-induced c-fos expression in the dorsal motor nucleus of the vagus and gastric erosions in rats. Brain Res. 736: 44-53, 1996.
51. Williams, C. L., J. M. Peterson, R. G. Villar, and T. F. Burks. Corticotropin-releasing factor directly mediates colonic responses to stress. Am. J. Physiol. 253 (Gastrointest. Liver Physiol. 16): G582-G586, 1987.